Ιn a world first, the UK medicines regulator has approved a therapy that uses the CRISPR–Cas9 gene-editing tool as a treatment. The therapy, called Casgevy, will treat the blood conditions…
CRISPR–Cas9
-
-
The first trial in humans of the precise gene-editing technique known as base editing, by using the CRISPR–Cas9 machinery, has shown promising results for keeping cholesterol levels in check. The…